title: Immunological response and protection of mice immunized with plasmid encoding Toxoplasma gondii glycolytic enzyme malate dehydrogenase.
abstract: Toxoplasma gondii Malate dehydrogenase (TgMDH) plays an important role as part of the energy production cycle. In this investigation, immunological changes and protection efficiency of this protein delivered as a DNA vaccine have been evaluated. Mice were intramuscularly immunized with pTgMDH, followed by challenge with virulent T. gondii RH strain, 2 weeks after the booster immunization. Compared to the control groups, the results showed that pTgMDH has stimulated specific humoral response as demonstrated by significant high titers of total IgG and subclasses IgG1 and IgG2a , beside IgA and IgM, but not IgE. Analysis of cytokine profiles revealed significant increases of IFN-γ, IL-4 and IL-17, while no significant changes were detected in TGF-β1. In cell-mediated response, both T lymphocytes subpopulations CD4(+) and CD8(+) were positively recruited as significant percentages were recorded in response to immunization with TgMDH. Significant long survival rate, 17 days, has been observed in the TgMDH vaccinated group, in contrast with control groups which died within 8-9 days after challenge. These results demonstrated that TgMDH could induce significant immunological responses leading to a considerable level of protection against acute toxoplasmosis infection.
authors.affiliation: Key Laboratory of Animal Diseases Diagnosis and Immunology, Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu, China.
authors.forename: I A
authors.initials: IA
authors.lastname: Hassan
authors.forename: S
authors.initials: S
authors.lastname: Wang
authors.forename: L
authors.initials: L
authors.lastname: Xu
authors.forename: R
authors.initials: R
authors.lastname: Yan
authors.forename: X
authors.initials: X
authors.lastname: Song
authors.forename: L
authors.initials: L
authors.lastname: XiangRui
mesh_terms: D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D016207:Cytokines / Q000097:blood; D005260:Female; D007273:Injections, Intramuscular; D008291:Malate Dehydrogenase / Q000235:genetics; D051379:Mice; D010957:Plasmids; D016052:Protozoan Vaccines / Q000008:administration & dosage / Q000276:immunology*; D013047:Specific Pathogen-Free Organisms; D013601:T-Lymphocytes / Q000276:immunology; D014122:Toxoplasma / Q000201:enzymology / Q000235:genetics / Q000502:physiology*; D014124:Toxoplasmosis, Animal / Q000276:immunology* / Q000517:prevention & control*; D019444:Vaccines, DNA / Q000276:immunology*
chemical_list: D000913:Antibodies, Protozoan; D016207:Cytokines; D016052:Protozoan Vaccines; D019444:Vaccines, DNA; D008291:Malate Dehydrogenase
keywords: DNA vaccines; Toxoplasma gondii; glycolysis; malate dehydrogenase; pTgMDH